TIGEN PHARMACEUTICALS

Company Information
Address UNIVERSITY OF KENTUCKY
ASTECC BLDG, RM 346
LEXINGTON, KY, 40506


Information

DUNS:

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Long Circulating Liposomal Camptothecins CAP and EAP

    Amount: $0.00

    DESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the fur ...

    STTRPhase I2001Department of Health and Human Services
  2. Long Circulating Liposomal Camptothecins CAP and EAP

    Amount: $284,000.00

    DESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the fur ...

    STTRPhase II2001Department of Health and Human Services
  3. Potent Topoisomerase I Inhibition For Glioma Therapy

    Amount: $133,125.00

    DESCRIPTION (PROVIDED BY APPLICANT): DB-67 is a promising new silatecan (silylcamptothecin) analog that displays superior blood stability relative to the FDA-approved camptothecin ...

    STTRPhase I2001Department of Health and Human Services
  4. N/A

    Amount: $100,000.00

    N/A

    STTRPhase I2000Department of Health and Human Services
  5. STABLE CAMPTOTHECIN FORMULATIONS FOR CANCER TREATMENT

    Amount: $100,000.00

    N/A

    STTRPhase I1998Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government